MENU
GKOS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Glaukos (GKOS) Earnings Date & Reports

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more

A.I. Advisor
published Earnings

GKOS is expected to report earnings to rise 28.06% to -20 cents per share on February 19

Glaukos GKOS Stock Earnings Reports
Q4'25
Est.
$-0.20
Q3'25
Beat
by $0.10
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.13
Q4'24
Missed
by $0.02
The last earnings report on October 29 showed earnings per share of -15 cents, beating the estimate of -25 cents. With 1.08M shares outstanding, the current market capitalization sits at 5.32B.
View a ticker or compare two or three
GKOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GKOS showed earnings on October 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

an ophthalmic medical device company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com